Sign in

CIK 0001526119

  • Non-accelerated filer
  • Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
273269467
Phone
+1 781-292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Open-market buy Director bought 10,000 shares at $8.54 ($85,435)
  2. 4 Open-market buy Chief Medical Officer bought 750 shares at $8.60 ($6,450)
  3. 4 Open-market buy Director bought 2,500 shares at $8.56 ($21,395)
  4. 4 Open-market buy Director bought 3,000 shares at $8.31 ($24,932)
  5. 4 Open-market buy Director bought 19,100 shares at an average $8.09 ($154,547)
  6. 4 Open-market buy Chief Financial Officer bought 500 shares at $8.17 ($4,085)
  7. 4 Open-market buy General Counsel bought 1,000 shares at $8.09 ($8,089)
  8. 4 Open-market buy Executive Chairman bought 1,500 shares at $8.50 ($12,750)
  9. 4 Open-market buy Chief Operating Officer bought 2,000 shares at $8.52 ($17,040)
  10. 4 Open-market buy President and CEO bought 1,000 shares at $8.66 ($8,660)
  11. 4 Open-market buy Director bought 2,500 shares at $9.17 ($22,923)
  12. 4 Shares withheld for taxes Executive Chairman gave up 2,762 shares (to pay taxes)
  13. 4 Open-market buy Director bought 3,000 shares at $9.10 ($27,300)
  14. 4 Shares withheld for taxes Cheif Business Officer gave up 6,373 shares (to pay taxes)
  15. 4 Shares withheld for taxes President & CEO gave up 8,206 shares (to pay taxes)
  16. 4 Shares withheld for taxes VP, Head of Research gave up 4,706 shares (to pay taxes)
  17. 4 Shares withheld for taxes Executive Chairman gave up 5,530 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 27 · 526 filings